510(k) K860493
K860493 is an FDA 510(k) premarket notification submitted by Cytotech, Inc. for the device "CYTOTECH CMV IGG EIA". The FDA issued a decision of Substantially Equivalent on May 20, 1986. The device falls under product code GQI (Antiserum, Cf, Cytomegalovirus), a Class II device regulated under 21 CFR 866.3175. Cytotech, Inc. has at least 9 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 20, 1986
- Date Received
- February 10, 1986
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antiserum, Cf, Cytomegalovirus
- Device Class
- Class II
- Regulation Number
- 866.3175
- Review Panel
- MI
- Submission Type